OKYO Pharma Limited – Filings and Transcripts

NASDAQ: OKYO
Share price (3/27/26): $1.53
Market cap (3/27/26): $51.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/25 FY 2025 – amended

ended 03/31/25 FY 2025

ended 03/31/24 FY 2024

Late filing notification for annual report of foreign issuer

ended 03/31/23 FY 2023 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Cerrone Gabriele M

Point72 Asset Management, L.P.

Dauntless Investment Group, LLC

News Filter

Announces Chairman and Founder Acquires Shares

Announces Director Acquires Shares

Announces Chief Development Officer and Director Acquires Shares

Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes With Urcosimod in Neuropathic Corneal Pain

Information Contained in This Report on Form 6-K

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC